Company Description
NYMX (NASDAQ: NYMX) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector. The company has a market capitalization of $18.3M.
NYMX stock has gained 16.2% over the past year.
This page provides a comprehensive overview of NYMX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
NYMX (NYMX) stock. Over the past 12 months, the stock has gained 16.2%. At a market capitalization of $18.3M, NYMX is classified as a micro-cap stock.
Latest News
NYMX has 10 recent news articles. Of the recent coverage, 8 articles coincided with positive price movement and 2 with negative movement. Key topics include clinical trial, management. View all NYMX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
NYMX Company Profile & Sector Positioning
NYMX (NYMX) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.